The company
BioNTech SE - American Depositary Shares
BNTX · Nasdaq
BNTX stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 34 weeks. It is 6.0% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 34
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $158.9M
- Officials’ trades on record
- 8
- Institutions holding
- 265 (+13)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
8 disclosed lines: House 8, Senate 0, executive 0; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Val T. Hoyle House: U.S. House ClerkOR04 | soldspouse | $1k–$15k | 7 Aug 2025filed 12 Sep 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 3 Sep 2024filed 3 Oct 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 30 Aug 2024filed 11 Sep 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 15 Apr 2024filed 15 May 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 14 Mar 2024filed 7 Apr 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 7 Dec 2023filed 7 Jan 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 6 Dec 2023filed 7 Jan 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 5 Dec 2023filed 7 Jan 2024 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Ugur SahinChief Executive Officer | sold | 36,209at $95.37 | 9 Oct 2026filed 9 Oct 2026 |
| Ugur SahinChief Executive Officer | sold | 27,000at $92.31 | 8 Oct 2026filed 9 Oct 2026 |
| Ugur SahinChief Executive Officer | sold | 24,000at $95.86 | 7 Oct 2026filed 7 Oct 2026 |
| Ugur SahinChief Executive Officer | sold | 21,000at $96.81 | 6 Oct 2026filed 6 Oct 2026 |
| Ugur SahinChief Executive Officer | sold | 72,000at $97.23 | 5 Oct 2026filed 6 Oct 2026 |
| Ugur SahinChief Executive Officer | sold | 17,000at $96.72 | 2 Oct 2026filed 2 Oct 2026 |
| Ugur SahinChief Executive Officer | sold | 17,000at $97.46 | 1 Oct 2026filed 2 Oct 2026 |
| Ugur SahinChief Executive Officer | sold | 32,000at $98.12 | 30 Sep 2026filed 30 Sep 2026 |
| Ugur SahinChief Executive Officer | sold | 34,000at $98.26 | 29 Sep 2026filed 30 Sep 2026 |
| Ugur SahinChief Executive Officer | sold | 34,000at $98.47 | 28 Sep 2026filed 28 Sep 2026 |
| Ugur SahinChief Executive Officer | sold | 27,000at $98.69 | 25 Sep 2026filed 28 Sep 2026 |
| Ugur SahinChief Executive Officer | sold | 39,000at $98.99 | 24 Sep 2026filed 24 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCadded · filed 13 Aug 2026 | 7,571,805$704.6M | +1,862,565+32.6% |
| PRIMECAP MANAGEMENT COreduced · filed 14 Aug 2026 | 3,772,031$351.0M | -21,680−0.6% |
| Dodge & Coxadded · filed 13 Aug 2026 | 3,677,591$342.2M | +8000.0% |
| FLOSSBACH VON STORCH SEreduced · filed 10 Aug 2026 | 2,226,138$207.1M | -1,454,177−39.5% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 1,854,966$172.6M | +196,813+11.9% |
| Temasek Holdings (Private) Ltdunchanged · filed 7 Aug 2026 | 1,506,027$140.1M | 00.0% |
| BNP PARIBAS FINANCIAL MARKETSreduced · filed 13 Aug 2026 | 1,319,517$122.8M | -332,272−20.1% |
| Logos Global Management LPnew · filed 14 Aug 2026 | 1,015,000$94.4M | +1,015,000 |
| GSK plcunchanged · filed 13 Aug 2026 | 889,824$82.8M | 00.0% |
| FIRST TRUST ADVISORS LPreduced · filed 11 Aug 2026 | 791,469$73.6M | -48,522−5.8% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
No ratio computed from its SEC filings yet.
Analyst forecasts
No analyst forecasts yet.